A molecule produced by gut bacteria can trigger heart disease, according to research published in Nature. Scientists at ...

Elucid, an AI medical technology company focused on providing physicians with a more precise view of atherosclerosis to drive patient-specific therapeutic decisions, has made two additions to its ...

Researchers at the University of Pittsburgh found that repeatedly consuming high-protein diets could lead to issues with heart health.

ImP administration to mouse model induced atherosclerosis without altering the lipid profile, and was associated with immune activation and inflammation.

Cardiovascular disease is the leading cause of death worldwide and often originates in atherosclerosis, a chronic condition in which inflammation and fat deposits cause arteries to harden and narrow.

A CNIC-led study has identified imidazole propionate, a metabolite produced by gut bacteria, as a driver of atherosclerosis—a ...

A bacterially produced molecule circulates in the bloodstream and increases the risk of cardiovascular disease by hijacking ...

Pfizer Inc. has identified signal transducer and activator of transcription 6 (STAT6) inhibitors reported to be useful for the treatment of Alzheimer’s disease, cancer, atherosclerosis, metabolic ...

PlaqueIQ is the first and only FDA-cleared, non-invasive plaque analysis based on objective histology. PlaqueIQ delivers automated quantification and classification of plaque morphology, and is ...

Using OCT to look at the burden, not just individual factors, helps provide clues on why disease develops—and how it ...

By Dr. Peter Haigh University of Kentucky We have known for decades that smoking tobacco is bad your health. Quitting smoking ...

Eli Lilly & Co. has divulged relaxin receptor 1 (RXFP1; LGR7) agonists reported to be useful for the treatment of diabetes, stroke, atherosclerosis, pulmonary hypertension, chronic obstructive ...